Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02970981
Title Study of Combination of Ipilimumab and Nivolumab in Patients With Melanoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors New York University School of Medicine
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA


No variant requirements are available.